文献速递生殖医学

预测择期卵母细胞冷冻后的活产可能性:面向医生和患者的咨询工具

Predicting the likelihood of live birth for elective oocyte cryopreservation: a counseling tool for physicians and patients.
PubMed 文献 · Hum Reprod · 2017-01-01

本研究基于2011年1月至2015年3月本中心520例ICSI周期数据,建立模型预测择期卵母细胞冷冻女性基于年龄和成熟卵母细胞数获得至少1、2或3次活产的概率,并开发咨询工具。模型假设冻卵存活率<36岁为95%、≥36岁为85%,每移植一个整倍体囊胚活产率60%。

要点

  • 基于年龄和冻存成熟卵母细胞数,可预测至少1、2或3次活产的概率。
  • 模型数据来自卵巢储备正常的ICSI患者,非实际解冻使用冻卵的女性。
  • 各中心应参考自身囊胚形成率和解冻存活率进行咨询。

核心结论

  • 研究基于卵巢储备正常人群的ICSI周期数据,建立了依据取卵年龄和冻存成熟卵母细胞数预测至少1、2或3次活产概率的循证模型,并据此设计咨询工具。
  • 该模型可为希望择期生育力保存的女性提供咨询资源,帮助了解活产可能性、需进行的周期数以及额外周期何时收益递减。

研究设计与样本

  • 利用2011年1月至2015年3月本中心因单纯男性因素和/或输卵管因素不孕以及供卵而行的ICSI周期(n=520)建立模型。
  • 分析首次新鲜自体ICSI周期(n=466)用泊松回归计算成熟卵母细胞形成囊胚的概率与年龄的关系;供卵周期(n=54)单独分析并纳入模型。
  • 整倍体概率估计自外部检测实验室的14500例PGS胚胎结果。
  • 假设冻卵存活率<36岁及供卵者为95%、≥36岁为85%,每个移植的整倍体囊胚活产率为60%,计算至少1、2或3次活产的概率。

主要发现

  • 研究提供了基于取卵时年龄和冻存成熟卵母细胞数预测至少1、2或3次活产概率的循证模型。
  • 模型来源于卵巢储备未受损的ICSI患者替代人群。
  • 利用该模型设计了用户友好的咨询工具以帮助指导医生和患者。

关键数值与推荐

  • 冻卵存活率假设:<36岁及供卵者为95%,≥36岁为85%。
  • 每个移植的整倍体囊胚活产率假设为60%。

临床怎么用

  • 各中心在咨询患者时应考虑自身的囊胚形成率和解冻存活率。
  • 该咨询工具可帮助希望择期生育力保存的女性了解活产可能性、需进行的周期数以及额外周期何时收益递减。

局限性

  • 用于开发预测模型的数据必然是回顾性的,且并非基于已解冻使用其冻存卵母细胞的患者。
  • 创建模型所用的假设虽然合理且有数据驱动,但因研究而异,且很可能因中心而异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Can a counseling tool be developed for women desiring elective oocyte cryopreservation to predict the likelihood of live birth based on age and number of oocytes frozen? SUMMARY ANSWER: Using data from ICSI cycles of a population of women with uncompromised ovarian reserve, an evidence-based counseling tool was created to guide women and their physicians regarding the number of oocytes needed to freeze for future family-building goals. WHAT IS KNOWN ALREADY: Elective oocyte cryopreservation is increasing in popularity as more women delay family building. By undertaking elective oocyte freezing at a younger age, women hope to optimize their likelihood of successful live birth(s) using their thawed oocytes at a future date. Questions often arise in clinical practice regarding the number of cryopreserved oocytes sufficient to achieve live birth(s) and whether or not additional stimulation cycles are likely to result in a meaningful increase in the likelihood of live birth. As relatively few women who have electively cryopreserved oocytes have returned to use them, available data for counseling patients wishing to undergo fertility preservation are limited. STUDY DESIGN, SIZE, DURATION: A model was developed to determine the proportion of mature oocytes that fertilize and then form blastocysts as a function of age, using women with presumably normal ovarian reserve based on standard testing who underwent ICSI cycles in our program from January, 2011 through March, 2015 (n = 520). These included couples diagnosed exclusively with male-factor and/or tubal-factor infertility, as well as cycles utilizing egg donation. Age-specific probabilities of euploidy were estimated from 14 500 PGS embryo results from an external testing laboratory. Assuming survival of thawed oocytes at 95% for women <36 y and for egg donors, and 85% for women ≥36 y, and 60% live birth rate per transferred euploid blastocyst, probabilities of having at least one, two or three live birth(s) were calculated. PARTICIPANTS/MATERIALS, SETTING, METHOD: First fresh male-factor and/or tubal-factor only autologous ICSI cycles (n = 466) were analyzed using Poisson regression to calculate the probability that a mature oocyte will become a blastocyst based on age. Egg donation cycles (n = 54) were analyzed and incorporated into the model separately. The proportion of blastocysts expected to be euploid was determined using PGS results of embryos analyzed via array comparative genomic hybridization. A counseling tool was developed to predict the likelihood of live birth, based on individual patient age and number of mature oocytes. MAIN RESULTS AND THE ROLE OF CHANCE: This study provides an evidence-based model to predict the probability of a woman having at least one, two or three live birth(s) based on her age at egg retrieval and the number of mature oocytes frozen. The model is derived from a surrogate population of ICSI patients with uncompromised ovarian reserve. A user-friendly counseling tool was designed using the model to help guide physicians and patients. LIMITATIONS, REASONS FOR CAUTION: The data used to develop the prediction model are, of necessity, retrospective and not based on patients who have returned to use their cryopreserved oocytes. The assumptions used to create the model, albeit reasonable and data-driven, vary by study and will likely vary by center. Centers are therefore encouraged to consider their own blastocyst formation and thaw survival rates when counseling patients. LIMITATIONS, REASONS FOR CAUTION: Our model will provide a counseling resource that may help inform women desiring elective fertility preservation regarding their likelihood of live birth(s), how many cycles to undergo, and when additional cycles would bring diminishing returns. STUDY FUNDING/COMPETING INTERESTS: None. TRIAL REGISTRATION NUMBER: Not applicable.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Goldman RH, Racowsky C, Farland LV, et al. Predicting the likelihood of live birth for elective oocyte cryopreservation: a counseling tool for physicians and patients. Hum Reprod. 2017. PMID: 28166330. doi:10.1093/humrep/dex008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。